Mihalikova Andrea, Baliova Martina, Jursky Frantisek
Laboratory of Neurobiology, Institute of Molecular Biology, Slovak Academy of Sciences, Dubravska cesta 21, 845 51 Bratislava, Slovakia.
Laboratory of Neurobiology, Institute of Molecular Biology, Slovak Academy of Sciences, Dubravska cesta 21, 845 51 Bratislava, Slovakia.
Neurosci Res. 2014 Apr-May;81-82:85-91. doi: 10.1016/j.neures.2014.02.007. Epub 2014 Feb 22.
Previously, we found that the C-terminus of the glycine transporter GlyT1 loses the most of its epitopes during pathological calcium increase in rodent synaptosomes but that the more internal epitopes are spared. We also found that epitope immunoreactivity likely decreases via both phosphorylation and calpain-mediated proteolysis. Here we show that the predicted phosphomimetic mutation S605D fully blocks the adjacent (T602/T603) internal calpain cleavage in the mouse GlyT1b C-terminal fusion protein, but that the neutral S605A mutation does not. Consistent with this, the phophomimetic mutation, but not the neutral mutation, significantly protected the internal GlyT1 C-terminal antiGlyT1C603-626 epitopes against calpain when introduced into tissue culture expressed GlyT1b. Because similar effects can be obtained using phosphatase inhibitors, it may be that phosphorylation of S605 protects the GlyT1 C-terminal sequences from calpain cleavage in vivo.
此前,我们发现,在啮齿动物突触体病理性钙升高过程中,甘氨酸转运体GlyT1的C末端大部分表位丧失,但更多内部表位得以保留。我们还发现,表位免疫反应性可能通过磷酸化和钙蛋白酶介导的蛋白水解作用而降低。在此我们表明,预测的拟磷酸化突变S605D完全阻断了小鼠GlyT1b C末端融合蛋白中相邻的(T602/T603)内部钙蛋白酶切割,但中性突变S605A则不然。与此一致的是,当引入到组织培养表达的GlyT1b中时,拟磷酸化突变而非中性突变能显著保护GlyT1 C末端抗GlyT1C603 - 626表位免受钙蛋白酶的作用。由于使用磷酸酶抑制剂可获得类似效果,所以可能是S605的磷酸化在体内保护了GlyT1 C末端序列免受钙蛋白酶切割。